Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2(nd) International Post-Tuberculosis Symposium
Details
Publication Year 2024-08-14,Volume 210,Issue #8,Page 979-993
Journal Title
American Journal of Respiratory and Critical Care Medicine
Abstract
Post-tuberculosis (TB) lung disease (PTLD) is increasingly recognized as a major contributor to the global burden of chronic lung disease, with recent estimates indicating that over half of TB survivors have impaired lung function after successful completion of TB treatment. However, the pathologic mechanisms that contribute to PTLD are not well understood, thus limiting the development of therapeutic interventions to improve long-term outcomes after TB. This report summarizes the work of the "Pathogenesis and Risk Factors Committee" for the Second International Post-Tuberculosis Symposium, which took place in Stellenbosch, South Africa in April 2023. The committee first identified six areas with high translational potential: (1) tissue matrix destruction, including the role of matrix metalloproteinase dysregulation and neutrophil activity, (2) fibroblasts and profibrotic activity, (3) granuloma fate and cell death pathways, (4) mycobacterial factors including pathogen burden, (5) animal models, and (6) the impact of key clinical risk factors including HIV, diabetes, smoking, malnutrition, and alcohol. We share here the key findings from a literature review of those areas, highlighting knowledge gaps and areas where further research is needed.
Publisher
ATS
Keywords
fibrosis; matrix metalloproteinases; neutrophils; post-tuberculosis lung disease; tuberculosis
Research Division(s)
Infectious Diseases And Immune Defence
PubMed ID
39141569
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2024-08-23 02:54:12
Last Modified: 2024-10-25 10:50:48
An error has occurred. This application may no longer respond until reloaded. Reload 🗙